Health Care & Life Sciences » Pharmaceuticals | BioDelivery Sciences International Inc.

BioDelivery Sciences International Inc. | Mutual Funds

Mutual Funds that own BioDelivery Sciences International Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
1,414,198
2.37%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
799,531
1.34%
7,400
0%
07/31/2018
Columbia Small Cap Value Fund I
739,545
1.24%
55,000
0.32%
05/31/2018
Royce Value Plus Fund
677,000
1.13%
87,000
0.51%
06/30/2018
Royce Low Priced Stock Fund
670,200
1.12%
172,700
0.7%
06/30/2018
Columbia Variable - Small Cap Value Fund
431,756
0.73%
0
0.32%
05/31/2018
Royce Micro Cap Fund
415,100
0.7%
33,500
0.59%
06/30/2018
Royce Capital Fund - Micro Cap Portfolio
411,700
0.69%
54,000
0.59%
06/30/2018
Grandeur Peak Global Opportunities Fund
407,328
0.68%
-135,872
0.15%
04/30/2018
APO Medical Opportunities
361,000
0.61%
59,100
0.2%
03/31/2018

About BioDelivery Sciences International

View Profile
Address
4131 ParkLake Avenue
Raleigh North Carolina 27612
United States
Employees -
Website http://www.bdsi.com
Updated 07/08/2019
BioDelivery Sciences International, Inc. is a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.